Lab-Grown tumor models could personalize mesothelioma care
NCT ID NCT07330271
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to choose cancer treatments for people with peritoneal mesothelioma. After surgery, doctors will grow a model of the patient's tumor in the lab and test different drugs on it to find the best match. The goal is to see if this personalized approach helps patients live longer without their cancer growing, compared to standard chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PERITONEAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tsinghua University affiliated Beijing Tsinghua Changgung Hospital
RECRUITINGBeijing, 102218, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Abdominal chemotherapy after surgery may improve mesothelioma outcomes
- Immune cells engineered to fight mesothelioma enter human testing
- New combo therapy targets rare abdominal cancer
- Heated chemo combo tested in abdominal cancer surgery
- New drug combo targets Hard-to-Treat cancers with genetic weakness
- New immunotherapy combo targets rare cancers left behind by progress